GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sofwave Medical Ltd (XTAE:SOFW) » Definitions » Debt-to-EBITDA

Sofwave Medical (XTAE:SOFW) Debt-to-EBITDA : -0.53 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sofwave Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sofwave Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪2.1 Mil. Sofwave Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪2.8 Mil. Sofwave Medical's annualized EBITDA for the quarter that ended in Dec. 2023 was ₪-9.1 Mil. Sofwave Medical's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.53.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sofwave Medical's Debt-to-EBITDA or its related term are showing as below:

XTAE:SOFW' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.37   Med: -0.11   Max: -0.01
Current: -0.2

During the past 6 years, the highest Debt-to-EBITDA Ratio of Sofwave Medical was -0.01. The lowest was -0.37. And the median was -0.11.

XTAE:SOFW's Debt-to-EBITDA is ranked worse than
100% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs XTAE:SOFW: -0.20

Sofwave Medical Debt-to-EBITDA Historical Data

The historical data trend for Sofwave Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sofwave Medical Debt-to-EBITDA Chart

Sofwave Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.02 -0.01 -0.37 -0.11 -0.20

Sofwave Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only -0.27 -0.13 -0.11 -0.15 -0.53

Competitive Comparison of Sofwave Medical's Debt-to-EBITDA

For the Medical Devices subindustry, Sofwave Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sofwave Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sofwave Medical's Debt-to-EBITDA falls into.



Sofwave Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sofwave Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.056 + 2.807) / -24.199
=-0.20

Sofwave Medical's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.056 + 2.807) / -9.14
=-0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Sofwave Medical  (XTAE:SOFW) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sofwave Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sofwave Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sofwave Medical (XTAE:SOFW) Business Description

Traded in Other Exchanges
N/A
Address
Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.

Sofwave Medical (XTAE:SOFW) Headlines

No Headlines